Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tobias T Fleischmann"'
Autor:
Sibah Alkatib, Lars B Scharff, Marcelo Rogalski, Tobias T Fleischmann, Annemarie Matthes, Stefanie Seeger, Mark A Schöttler, Stephanie Ruf, Ralph Bock
Publikováno v:
PLoS Genetics, Vol 8, Iss 11, p e1003076 (2012)
Reduced bacterial genomes and most genomes of cell organelles (chloroplasts and mitochondria) do not encode the full set of 32 tRNA species required to read all triplets of the genetic code according to the conventional wobble rules. Superwobbling, i
Externí odkaz:
https://doaj.org/article/7c1572ab134c400eb857bb15f6c69a9a
Publikováno v:
Nucleic Acids Research
The plastid (chloroplast) genomes of seed plants typically encode 30 tRNAs. Employing wobble and superwobble mechanisms, most codon boxes are read by only one or two tRNA species. The reduced set of plastid tRNAs follows the evolutionary trend of org
Autor:
Sibah Alkatib, Sebastian Hasdorf, Lars B. Scharff, Ralph Bock, Tobias T. Fleischmann, Mark Aurel Schöttler
Publikováno v:
The Plant Cell
Plastid genomes of higher plants contain a conserved set of ribosomal protein genes. Although plastid translational activity is essential for cell survival in tobacco (Nicotiana tabacum), individual plastid ribosomal proteins can be nonessential. Can
Autor:
Günter Assum, Tobias T. Fleischmann
One of the hallmarks of prostate cancer development is the amplification of C-MYC copy numbers. It is not yet clear what the driving force behind the activation of C-MYC expression in prostate cancer is. CTCF, which is known for its role as chromatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d1d111532b5b58824c27b4e32675fc8
Autor:
Ralph Bock, Tobias T. Fleischmann, Claudia Hasse, Miriam Ehrnthaler, Lars B. Scharff, Stephanie Ruf
Publikováno v:
The Plant Cell
Consistent with their origin from cyanobacteria, plastids (chloroplasts) perform protein biosynthesis on bacterial-type 70S ribosomes. The plastid genomes of seed plants contain a conserved set of ribosomal protein genes. Three of these have proven t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f7c9bd590368aa3add506a5b3487ad5
https://hdl.handle.net/11858/00-001M-0000-0019-CDA0-3
https://hdl.handle.net/11858/00-001M-0000-0019-CDA0-3
Autor:
Fleischmann T; Pfizer Pharma GmbH.
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2024 Oct 18. Date of Electronic Publication: 2024 Oct 18.
Autor:
Mizoguchi H; Astellas Pharma Inc., Regulatory Affairs, Chuo-ku, Tokyo, Japan.; Forum for Innovative Regenerative Medicine, Chuo-ku, Tokyo, Japan., Fleischmann T; Pfizer Pharma, GmbH, Biotransformation and Environmental Sciences, Berlin, Germany., Komuro M; Sanofi K.K., Regulatory Affairs, Shinjuku-ku, Tokyo, Japan.; Japan Pharmaceutical Manufacturers Association, Chuo-ku, Tokyo, Japan., Hirai T; GlaxoSmithKline K.K., Akasaka Intercity AIR, Minato-ku, Tokyo, Japan.; EFPIA Japan (European Federation of Pharmaceutical Industries and Associations, Japan), Shinjuku-ku, Tokyo, Japan., Ikeda A; Janssen Japan K.K., Regulatory Affairs, Chiyoda-ku, Tokyo, Japan., Saito K; EFPIA Japan (European Federation of Pharmaceutical Industries and Associations, Japan), Shinjuku-ku, Tokyo, Japan.; Chugai Pharmaceutical Co. Ltd., Regulatory Affairs, Chuo-ku, Tokyo, Japan., Watahiki T; Janssen Japan K.K., Regulatory Affairs, Chiyoda-ku, Tokyo, Japan., Tajima G; Pfizer R&D Japan G.K., Regulatory Sciences, Shibuya-ku, Tokyo, Japan.
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2024 Jun; Vol. 24 (6), pp. 529-542. Date of Electronic Publication: 2024 Jun 28.
Autor:
Fleischmann T; Pfizer Pharma GmbH, Linkstr 10, 10785 Berlin, Germany. Electronic address: Tobias.Fleischmann@pfizer.com.
Publikováno v:
Journal of environmental management [J Environ Manage] 2023 Nov 01; Vol. 345, pp. 118754. Date of Electronic Publication: 2023 Aug 31.
Autor:
Tajima G; Pfizer R&D Japan G.K., Regulatory Affairs, Shibuya-ku, 3-22-7, Yoyogi, Shibuya-ku, Tokyo 151-8589, Japan., Huh S; Pfizer, Inc., Global Regulatory Affairs, Lake Forest, IL, USA., Schmidt NA; Pfizer R&D, Ltd., Global Regulatory Affairs, Walton, Oaks, UK., Macdonald JC; Pfizer R&D, Ltd., Global Regulatory Policy, Walton, Oaks, UK., Fleischmann T; Pfizer Pharma, GmbH, Biotransformation and Environmental Sciences, Germany., Wonnacott KM; Pfizer, Inc., Global Regulatory Affairs, Gaithersburg, MD, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2022 May 28; Vol. 26, pp. 74-83. Date of Electronic Publication: 2022 May 28 (Print Publication: 2022).
Autor:
Bielczyk-Maczyńska E; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom.; NHS Blood and Transplant, Cambridge, United Kingdom., Lam Hung L; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom., Ferreira L; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom., Fleischmann T; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Medical Research, Cambridge, United Kingdom.; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Weis F; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Medical Research, Cambridge, United Kingdom.; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Fernández-Pevida A; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Medical Research, Cambridge, United Kingdom.; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Harvey SA; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom., Wali N; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom., Warren AJ; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Medical Research, Cambridge, United Kingdom.; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Barroso I; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom., Stemple DL; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom., Cvejic A; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, United Kingdom.; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Publikováno v:
PLoS genetics [PLoS Genet] 2015 Dec 01; Vol. 11 (12), pp. e1005677. Date of Electronic Publication: 2015 Dec 01 (Print Publication: 2015).